Laboratory Diagnostics
ELISA Immunoassay CLIA Immunoassay Molecular Diagnostics Point-of-Care Testing Precision Oncology & Liquid Biopsy

SUPPORT:

> Documents

> Scientific Posters

Testing Beyond the Laboratory

GBC develops rapid diagnostic tests designed to bring testing closer to patients and users. Our current POCT portfolio includes lateral flow immunoassays for professional and at-home testing, providing convenient testing options across different settings.

GBC continues to expand its rapid testing capabilities to support convenient and accessible diagnostic testing.

PRODUCTS

Showing 1–2 of 2 results
GB COVID-19 Ag Rapid Test (Self-testing) A lateral flow immunoassay that allows for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs specimens directly from individuals who are suspected of COVID-19.
GB COVID-19 Ag POCT (Professional) A lateral flow immunoassay that allows for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swabs specimens directly from individuals who are suspected of COVID-19 by their healthcare provider.

LOOKING FOR RAPID TESTING SOLUTIONS?

Contact our team to learn more about GBC point-of-care and rapid testing products.

Contact Us